Erin Healy provides regulatory advice and strategic guidance to healthcare and life sciences clients on a variety of corporate, transactional and regulatory matters with an acute awareness of the complex business and legal issues specific to the healthcare industry and a thorough understanding of the applicable law.
Erin routinely counsels pharmaceutical manufacturers, pharmacies, physicians and benefit providers on state and federal regulatory requirements, including fraud and abuse laws, self-referral laws, anti-kickback rules, FDA regulations and HIPAA. She also advises clients in connection with sales, mergers, acquisitions, joint ventures, provider contracts, reimbursement, commercial agreements, state licensing and general contracting.
Erin is also experienced in the design and construction fields and regularly drafts, reviews and negotiates construction contracts for clients across a variety of industries. She has helped clients navigate issues and legal challenges arising during the design development and construction phases of a range of complex projects including office buildings and pharmaceutical manufacturing facilities.
Erin previously managed clinical trials at top academic medical centers in New York City and contributed to several published, peer-reviewed articles on surgical and clinical outcomes, affording her substantial experience developing clinical trial agreements and a strong background in federal and institutional research regulations.
Erin is a contributor to Day Pitney's Healthcare Law Blog.